About 2,740 results

ALLMedicine™ IgA Nephropathy Center

Research & Reviews  1,021 results

Anti-glomerular basement membrane disease and IgA nephropathy in a patient with previou...
BMJ Case Reports; Khor C, Wong MG et. al.

Jul 29th, 2021 - A 66-year-old Asian woman presented with severe kidney injury, microscopic haematuria and subnephrotic range proteinuria with elevated serum anti-glomerular basement membrane (anti-GBM) titre. She had a history of renal cell carcinoma. Renal biops...

Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis in chronic ...
Nephrology, Dialysis, Transplantation : Official Publicat... Liu Y, Zhang GM et. al.

Jul 25th, 2021 - Renal fibrosis is the strongest prognosis predictor of end-stage renal disease (ESRD) in chronic kidney disease (CKD). Diffusion kurtosis imaging (DKI) is a promising method of magnetic resonance imaging (MRI) successfully used to assess renal fib...

Preliminary study on the application of renal ultrasonography radiomics in the classifi...
BMC Medical Imaging; Zhang L, Chen Z et. al.

Jul 25th, 2021 - The aim of this study was to investigate the potential use of renal ultrasonography radiomics features in the histologic classification of glomerulopathy. A total of 623 renal ultrasound images from 46 membranous nephropathy (MN) and 22 IgA nephro...

MIR17HG genetic variations affect the susceptibility of IgA nephropathy in Chinese Han ...
Gene Yang K, Zhang Y et. al.

Jul 19th, 2021 - Immunoglobulin A nephropathy (IgAN) is the most common primary glomerular disease worldwide. It accounts for approximately 30 ~ 40% of glomerular diseases in China. However, the exact pathogenesis of IgAN is not well established. This study aimed ...

see more →

Guidelines  1 results

Evidence-based clinical practice guidelines for IgA nephropathy 2014.
Clinical and Experimental Nephrology; Yuzawa Y, Yamamoto R et. al.

Apr 21st, 2016 - Evidence-based clinical practice guidelines for IgA nephropathy 2014.|2016|Yuzawa Y,Yamamoto R,Takahashi K,Katafuchi R,Tomita M,|diagnosis,etiology,therapy,

see more →

Clinicaltrials.gov  45 results

Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

Jan 27th, 2020 - IgA nephropathy (IgAN) is a histologically defined glomerulonephritis (renal biopsy) by the presence of deposits immunoglobulin A (IgA) in the renal mesangium (at least 1+) by immunofluorescence. The clinic allows excluding secondary forms (10-15%...

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Dec 24th, 2019 - This multi-center, open-label Phase 2 trial will study the safety, tolerability, and efficacy of bardoxolone methyl in qualified patients with the following rare chronic kidney diseases (CKD): CKD associated with type 1 diabetes (T1D), IgA nephrop...

Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy

Sep 6th, 2018 - The effect of tonsillectomy therapy on IgA nephropathy is still controversial.Few prospective,randomized investigations have examined how tonsillectomy affects the shortterm and longterm renal outcome of IgA nephropathy.This is A prospective,rando...

IgA Nephropathy Registration Initiative of High Quality (INSIGHT)

Sep 6th, 2018 - The investigators are registering all biopsy-proven primary IgA nephropathy (IgAN) patients, and developing a IgAN database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and educati...

Pathology of Hepatitis c Nephropathy

Mar 23rd, 2018 - Hepatitis C virus infection is a major public health problem with an estimated global prevalence of 3% and an estimated 5-20% of infected patients will develop liver cirrhosis .The Prevalence of Hepatitis C infection in end stage renal disease is ...

see more →

News  25 results

Complement Inhibitor Shows Early Promise in IgA Nephropathy

Jun 9th, 2021 - A first-in-class oral inhibitor of the alternative complement pathway that drives the pathogenesis of primary glomerulonephritis, iptacopan (LNP023, Novartis), is showing early promise as the first targeted therapy for the treatment of IgA nephrop...

New DAPA-CKD Analysis Hints at Dapagliflozin for IgA Nephropathy

Apr 20th, 2021 - Treatment with the sodium-glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin (Farxiga) was safe and effective for slowing progression of chronic kidney disease (CKD) and the development of end-stage renal disease for patients with immunoglobu...

Rash on legs and abdomen
MDedge Family Medicine;

Jan 16th, 2020 - The rash was consistent with nonblanching purpura. Two punch biopsies were performed for hematoxylin and eosin stain and direct immunofluorescence, which were consistent with IgA mediated small vessel vasculitis, or Henoch-Schoenlein purpura.

HCV, HBV, and HIV associated with autoimmune kidney diseases
Mark S. Lesney

Oct 23rd, 2018 - Chronic viral infection can be associated with a variety of autoimmune kidney diseases, according to a review published in Rheumatic Disease Clinics. London_England/Thinkstock In particular, hepatitis C virus (HCV) infection can cause several kidn.

Steroids for IgA Nephropathy: Risks Outweigh Benefits in Some

Aug 7th, 2017 - A high rate of serious adverse events led to the premature termination of a clinical trial designed to evaluate the efficacy of oral methylprednisolone in patients with immunoglobulin A (IgA) nephropathy despite evidence of a statistically signifi...

see more →

Patient Education  4 results see all →